{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:41:29Z","timestamp":1791999689880,"version":"4.4.0"},"reference-count":245,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T00:00:00Z","timestamp":1685923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Hypertensive heart disease constitutes functional and structural dysfunction and pathogenesis occurring primarily in the left ventricle, the left atrium and the coronary arteries due to chronic uncontrolled hypertension. Hypertensive heart disease is underreported and the mechanisms underlying its correlates and complications are not well elaborated. In this review, we summarize the current understanding of hypertensive heart disease, we discuss in detail the mechanisms associated with development and complications of hypertensive heart disease especially left ventricular hypertrophy, atrial fibrillation, heart failure and coronary artery disease. We also briefly highlight the role of dietary salt, immunity and genetic predisposition in hypertensive heart disease pathogenesis.<\/jats:p>","DOI":"10.3389\/fcvm.2023.1205475","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T05:21:46Z","timestamp":1685942506000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":126,"title":["Hypertensive heart disease: risk factors, complications and mechanisms"],"prefix":"10.3389","volume":"10","author":[{"given":"Sepiso K.","family":"Masenga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet","family":"Kirabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/HJH.0000000000002843","article-title":"2021 European society of hypertension practice guidelines for office and out-of-office blood pressure measurement","volume":"39","author":"Stergiou","year":"2021","journal-title":"J Hypertens"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International society of hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"B5","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s40119-019-0144-3","article-title":"New American and European hypertension guidelines, reconciling the differences","volume":"8","author":"de la Sierra","year":"2019","journal-title":"Cardiol Ther"},{"key":"B6","article-title":"Hypertensive heart disease: a new clinical classification (VIA)","volume":"7","author":"Gonzalez-Maqueda","year":"2009","journal-title":"e-Journal of Cardiology Practice"},{"key":"B7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.47162\/RJME.62.3.08","article-title":"Hypertension induces compensatory left ventricular hypertrophy by a mechanism involving gap junction lateralization and overexpression of CD36, PKC and MMP-2","volume":"62","author":"Dumitrescu","year":"2021","journal-title":"Rom J Morphol Embryol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1007\/s00125-005-1893-1","article-title":"Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study","volume":"48","author":"Boner","year":"2005","journal-title":"Diabetologia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1161\/01.CIR.92.4.805","article-title":"Left ventricular hypertrophy has a greater impact on survival in women than in men","volume":"92","author":"Liao","year":"1995","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e12067","DOI":"10.1097\/MD.0000000000012067","article-title":"Impact of left ventricular hypertrophy on long-term clinical outcomes in hypertensive patients who underwent successful percutaneous coronary intervention with drug-eluting stents","volume":"97","author":"Kim","year":"2018","journal-title":"Medicine"},{"key":"B11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"Zhou","year":"2021","journal-title":"Lancet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1186\/s12889-022-13271-0","article-title":"Global, regional, and national burden of hypertensive heart disease during 1990\u20132019: an analysis of the global burden of disease study 2019","volume":"22","author":"Lu","year":"2022","journal-title":"BMC Public Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/HYPERTENSIONAHA.120.16483","article-title":"Worldwide trends in prevalence, mortality, and disability-adjusted life years for hypertensive heart disease from 1990 to 2017","volume":"77","author":"Dai","year":"2021","journal-title":"Hypertension"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1161\/01.HYP.0000128738.94190.9f","article-title":"Differences in left ventricular structure between black and white hypertensive adults","volume":"43","author":"Kizer","year":"2004","journal-title":"Hypertension"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/j.jacc.2008.04.065","article-title":"Ethnicity and left ventricular diastolic function in hypertension: an ASCOT (anglo-scandinavian cardiac outcomes trial) substudy","volume":"52","author":"Sharp","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e006472","DOI":"10.1161\/CIRCHEARTFAILURE.119.006472","article-title":"Risk factors for heart failure","volume":"13","author":"Lawson","year":"2020","journal-title":"Circ Heart Fail"},{"key":"B18","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.jchf.2017.04.012","article-title":"The transition from hypertension to heart failure: contemporary update","volume":"5","author":"Messerli","year":"2017","journal-title":"JACC Heart Fail"},{"key":"B19","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.118.12572","article-title":"Blood pressure control and the association with diabetes incidence: results from the SPRINT randomized trial","volume":"75","author":"Roumie","year":"2020","journal-title":"Hypertension"},{"key":"B20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.hfc.2019.06.003","article-title":"Hypertensive heart disease and obesity: a review","volume":"15","author":"Saliba","year":"2019","journal-title":"Heart Fail Clin"},{"key":"B21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s40292-014-0068-x","article-title":"Left ventricular hypertrophy and obesity: only a matter of fat?","volume":"22","author":"Murdolo","year":"2015","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"B22","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1093\/eurheartj\/eht099","article-title":"Human epicardial adipose tissue induces fibrosis of the atrial myocardium through the secretion of adipo-fibrokines","volume":"36","author":"Venteclef","year":"2015","journal-title":"Eur Heart J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/mrm.10372","article-title":"Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging","volume":"49","author":"Szczepaniak","year":"2003","journal-title":"Magn Reson Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s11906-022-01222-4","article-title":"Immune cell activation in obesity and cardiovascular disease","volume":"24","author":"Garcia","year":"2022","journal-title":"Curr Hypertens Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1097\/HCO.0000000000000868","article-title":"Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure","volume":"36","author":"daSilva-deAbreu","year":"2021","journal-title":"Curr Opin Cardiol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1161\/HYPERTENSIONAHA.119.14240","article-title":"High blood pressure and cardiovascular disease","volume":"75","author":"Fuchs","year":"2020","journal-title":"Hypertension"},{"key":"B27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1093\/bja\/aeh091","article-title":"Hypertension, hypertensive heart disease and perioperative cardiac risk\u2020","volume":"92","author":"Howell","year":"2004","journal-title":"BJA: British Journal of Anaesthesia"},{"key":"B28","doi-asserted-by":"publisher","first-page":"S352","DOI":"10.1016\/j.ajog.2021.11.592","article-title":"Patients with chronic hypertension are at increased risk for postpartum cardiovascular disease complications","volume":"226","author":"Rosenfeld","year":"2022","journal-title":"Am J Obstetr Gynecol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1161\/01.CIR.102.4.470","article-title":"Left ventricular hypertrophy","volume":"102","author":"Lorell","year":"2000","journal-title":"Circulation"},{"key":"B30","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/eurheartj\/ehx381","article-title":"Staging classification of aortic stenosis based on the extent of cardiac damage","volume":"38","author":"G\u00e9n\u00e9reux","year":"2017","journal-title":"Eur Heart J"},{"key":"B31","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1093\/ajh\/hpx181","article-title":"Left ventricular hypertrophy predicts cardiovascular events in hypertensive patients with coronary artery calcifications","volume":"31","author":"Grossman","year":"2018","journal-title":"Am J Hypertens"},{"key":"B32","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/ajh\/hpx067","article-title":"Electrocardiographic left ventricular hypertrophy predicts cardiovascular morbidity and mortality in hypertensive patients: the ALLHAT study","volume":"30","author":"Bang","year":"2017","journal-title":"Am J Hypertens"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e006619","DOI":"10.1161\/JAHA.117.006619","article-title":"\u201cMalignant\u201d left ventricular hypertrophy identifies subjects at high risk for progression to asymptomatic left ventricular dysfunction, heart failure, and death: mESA (multi-ethnic study of atherosclerosis)","volume":"7","author":"Peters","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B34","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.jchf.2014.12.018","article-title":"Older adults, \u201cmalignant\u201d left ventricular hypertrophy, and associated cardiac-specific biomarker phenotypes to identify the differential risk of new-onset reduced versus preserved ejection fraction heart failure: cHS (cardiovascular health study)","volume":"3","author":"Seliger","year":"2015","journal-title":"JACC Heart Fail"},{"key":"B35","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1161\/CIRCULATIONAHA.119.043628","article-title":"Racial differences in malignant left ventricular hypertrophy and incidence of heart failure: a multicohort study","volume":"141","author":"Lewis","year":"2020","journal-title":"Circulation"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1016\/j.jacc.2022.08.735","article-title":"Intensive blood pressure lowering in patients with malignant left ventricular hypertrophy","volume":"80","author":"Ascher","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/ajh\/hpv071","article-title":"Sex differences in the associations of hemodynamic load with left ventricular hypertrophy and concentric remodeling","volume":"29","author":"Coutinho","year":"2016","journal-title":"Am J Hypertens"},{"key":"B38","first-page":"334","article-title":"Sex differences in the correlation between obesity and hypertension with left ventricular mass and hypertrophy","volume":"85","author":"Kuch","year":"1996","journal-title":"Z Kardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ijcard.2017.12.086","article-title":"Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the campania salute network)","volume":"258","author":"Gerdts","year":"2018","journal-title":"Int J Cardiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1161\/HYPERTENSIONAHA.106.079426","article-title":"The fuzzy logic of physiological cardiac hypertrophy","volume":"49","author":"Dorn","year":"2007","journal-title":"Hypertension"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1161\/01.cir.99.14.1822","article-title":"Impaired force-frequency relations in patients with hypertensive left ventricular hypertrophy. A possible physiological marker of the transition from physiological to pathological hypertrophy","volume":"99","author":"Inagaki","year":"1999","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jash.2011.08.006","article-title":"Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)\u2014possible therapeutic perspectives","volume":"5","author":"Cacciapuoti","year":"2011","journal-title":"J Am Soc Hypertens"},{"key":"B43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1139\/cjpp-2019-0566","article-title":"Mechanisms for the transition from physiological to pathological cardiac hypertrophy","volume":"98","author":"Oldfield","year":"2020","journal-title":"Can J Physiol Pharmacol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.pcad.2006.02.001","article-title":"From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease","volume":"48","author":"Gradman","year":"2006","journal-title":"Prog Cardiovasc Dis"},{"key":"B45","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1152\/physiol.00033.2006","article-title":"Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets","volume":"22","author":"Diwan","year":"2007","journal-title":"Physiology"},{"key":"B46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1161\/CIRCIMAGING.113.001275","article-title":"Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients","volume":"7","author":"Bang","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1152\/japplphysiol.00374.2015","article-title":"Myocardial hypertrophy and its role in heart failure with preserved ejection fraction","volume":"119","author":"Heinzel","year":"2015","journal-title":"J Appl Physiol (1985)"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1016\/j.jacc.2019.09.063","article-title":"Echocardiographic features of patients with heart failure and preserved left ventricular ejection fraction","volume":"74","author":"Shah","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/HYPERTENSIONAHA.107.107474","article-title":"Gender differences in left ventricular structure and function during antihypertensive treatment","volume":"51","author":"Gerdts","year":"2008","journal-title":"Hypertension"},{"key":"B50","doi-asserted-by":"publisher","first-page":"e004152","DOI":"10.1161\/JAHA.116.004152","article-title":"Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the campania salute network)","volume":"6","author":"L\u00f8nnebakken","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/01.CIR.0000141573.44737.5A","article-title":"Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol","volume":"110","author":"Devereux","year":"2004","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0002-9343(03)00158-X","article-title":"A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension","volume":"115","author":"Klingbeil","year":"2003","journal-title":"Am J Med"},{"key":"B53","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.numecd.2008.12.012","article-title":"Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study","volume":"19","author":"de Simone","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e000144","DOI":"10.1161\/JAHA.113.000144","article-title":"Lack of reduction of left ventricular mass in treated hypertension: the strong heart study","volume":"2","author":"de Simone","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"B55","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/s0735-1097(01)01386-9","article-title":"Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations","volume":"38","author":"Maron","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e0216359","DOI":"10.1371\/journal.pone.0216359","article-title":"Plasma protein thiolation index (PTI) as a potential biomarker for left ventricular hypertrophy in humans","volume":"14","author":"Quintana-Villamandos","year":"2019","journal-title":"PLoS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"e003191","DOI":"10.1161\/CIRCGEN.120.003191","article-title":"Multiomic profiling in black and white populations reveals novel candidate pathways in left ventricular hypertrophy and incident heart failure specific to black adults","volume":"14","author":"Katz","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"B58","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/ijms17070797","article-title":"Role of the renin-angiotensin-aldosterone system beyond blood pressure regulation: molecular and cellular mechanisms involved in End-organ damage during arterial hypertension","volume":"17","author":"Mu\u00f1oz-Durango","year":"2016","journal-title":"Int J Mol Sci"},{"key":"B59","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/emmm.201000080","article-title":"Angiotensin II revisited: new roles in inflammation, immunology and aging","volume":"2","author":"Benigni","year":"2010","journal-title":"EMBO Mol Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1161\/01.cir.96.1.148","article-title":"Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans","volume":"96","author":"Saino","year":"1997","journal-title":"Circulation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1161\/01.HYP.35.6.1183","article-title":"Angiotensin II and the heart","volume":"35","author":"De Mello","year":"2000","journal-title":"Hypertension"},{"key":"B62","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3858\/emm.2010.42.10.069","article-title":"Heat shock protein 90 regulates I\u03baB kinase complex and NF-\u03baB activation in angiotensin II-induced cardiac cell hypertrophy","volume":"42","author":"Lee","year":"2010","journal-title":"Exp Mol Med"},{"key":"B63","doi-asserted-by":"publisher","first-page":"48617","DOI":"10.1074\/jbc.M206532200","article-title":"Requirement of nuclear factor of activated T-cells in calcineurin-mediated cardiomyocyte hypertrophy","volume":"277","author":"van Rooij","year":"2002","journal-title":"J Biol Chem"},{"key":"B64","doi-asserted-by":"publisher","first-page":"0963689720920830","DOI":"10.1177\/0963689720920830","article-title":"Cardiovascular changes associated with hypertensive heart disease and aging","volume":"29","author":"Saheera","year":"2020","journal-title":"Cell Transplant"},{"key":"B65","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1002\/ehf2.12555","article-title":"Highlights in heart failure","volume":"6","author":"Tomasoni","year":"2020","journal-title":"ESC Heart Fail"},{"key":"B67","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/ejhf.2115","article-title":"Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure","volume":"23","author":"Bozkurt","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e876","DOI":"10.1161\/CIR.0000000000001062","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"B70","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.cardfail.2021.10.006","article-title":"Sex differences in heart failure","volume":"28","author":"Lala","year":"2022","journal-title":"J Card Fail"},{"key":"B71","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/978-3-319-77932-4_27","article-title":"Sex-specific physiology and cardiovascular disease","volume":"1065","author":"Shufelt","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/978-3-319-77932-4_32","article-title":"Sex differences in heart Failure","volume":"1065","author":"Savarese","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1093\/eurheartj\/ehs411","article-title":"Update on acute coronary syndromes: the pathologists\u2019 view","volume":"34","author":"Falk","year":"2013","journal-title":"Eur Heart J"},{"key":"B74","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41569-020-00480-6","article-title":"Cellular and molecular pathobiology of heart failure with preserved ejection fraction","volume":"18","author":"Mishra","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jjcc.2019.07.011","article-title":"Effects of carvedilol vs bisoprolol on inflammation and oxidative stress in patients with chronic heart failure","volume":"75","author":"Toyoda","year":"2020","journal-title":"J Cardiol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40256-018-00320-6","article-title":"Clinical pharmacokinetics, safety, and tolerability of a novel, first-in-class TRPV4 Ion channel inhibitor, GSK2798745, in healthy and heart failure subjects","volume":"19","author":"Goyal","year":"2019","journal-title":"Am J Cardiovasc Drugs"},{"key":"B77","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-med-042220-022745","article-title":"Heart failure with preserved ejection fraction: mechanisms and treatment strategies","volume":"73","author":"Omote","year":"2022","journal-title":"Annu Rev Med"},{"key":"B78","doi-asserted-by":"publisher","first-page":"2242","DOI":"10.1007\/s10439-015-1266-y","article-title":"Noninvasive characterization of vascular tone by model-based system identification in healthy and heart failure patients","volume":"43","author":"Zheng","year":"2015","journal-title":"Ann Biomed Eng"},{"key":"B79","doi-asserted-by":"publisher","first-page":"e000991","DOI":"10.1161\/JAHA.114.000991","article-title":"Abnormal stress-related measures of arterial stiffness in middle-aged and elderly men and women with impaired fasting glucose at risk for a first episode of symptomatic heart failure","volume":"4","author":"Vasu","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"B80","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1093\/europace\/eux091","article-title":"Hypertension and cardiac arrhythmias: a consensus document from the European heart rhythm association (EHRA) and ESC council on hypertension, endorsed by the heart rhythm society (HRS), Asia-pacific heart rhythm society (APHRS) and sociedad latinoamericana de estimulaci\u00f3n card\u00edaca y electrofisiolog\u00eda (SOLEACE)","volume":"19","author":"Lip","year":"2017","journal-title":"Europace"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1002\/rth2.12351","article-title":"Atrial fibrillation, venous thromboembolism, ischemic stroke, and all-cause mortality: the troms\u00f8 study","volume":"4","author":"Hald","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"B82","doi-asserted-by":"publisher","first-page":"e006502","DOI":"10.1161\/JAHA.117.006502","article-title":"Atrial fibrillation and cause-specific risks of pulmonary embolism and ischemic stroke","volume":"7","author":"Hald","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B83","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1161\/STROKEAHA.114.008421","article-title":"Increased stroke risk in atrial fibrillation patients with heart failure","volume":"46","author":"Kotecha","year":"2015","journal-title":"Stroke"},{"key":"B84","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jnma.2017.07.003","article-title":"Risk factors influencing outcomes of atrial fibrillation in ALLHAT","volume":"110","author":"Haywood","year":"2018","journal-title":"J Natl Med Assoc"},{"key":"B85","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/cphy.c140047","article-title":"Atrial fibrillation: mechanisms, therapeutics, and future directions","volume":"5","author":"Pellman","year":"2015","journal-title":"Compr Physiol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01458","article-title":"Atrial fibrillation mechanisms and implications for catheter ablation","volume":"9","author":"Cheniti","year":"2018","journal-title":"Front Physiol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"136","DOI":"10.2174\/1573403X15666181205110624","article-title":"Gender differences in atrial fibrillation: a review of epidemiology, management, and outcomes","volume":"15","author":"Westerman","year":"2019","journal-title":"Curr Cardiol Rev"},{"key":"B88","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1038\/sj.jhh.1001345","article-title":"Hypertension and coronary heart disease","author":"Escobar","year":"2002","journal-title":"J Hum Hypertens"},{"key":"B89","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1741-7015-11-117","article-title":"Immunity, atherosclerosis and cardiovascular disease","volume":"11","author":"Frosteg\u00e5rd","year":"2013","journal-title":"BMC Med"},{"key":"B90","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1161\/01.ATV.0000095976.40874.E0","article-title":"Relationship between the dynamic geometry and wall thickness of a human coronary artery","volume":"23","author":"Zhu","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"e653903","DOI":"10.4061\/2011\/653903","article-title":"Management of hypertension among patients with coronary heart disease","volume":"2011","author":"Olafiranye","year":"2011","journal-title":"Int J Hypertens"},{"key":"B92","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1111\/j.1751-7176.2007.tb00006.x","article-title":"Hypertension and coronary artery disease: a summary of the American heart association scientific statement","volume":"9","author":"Rosendorff","year":"2007","journal-title":"J Clin Hypertens"},{"key":"B93","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_106_17","article-title":"Risk factors for coronary artery disease: historical perspectives","volume":"18","author":"Hajar","year":"2017","journal-title":"Heart Views"},{"key":"B94","first-page":"67","article-title":"Hypertension and coronary heart disease","volume":"14","author":"Cubrilo-Turek","year":"2003","journal-title":"EJIFCC"},{"key":"B95","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/j.numecd.2010.02.013","article-title":"Coronary artery disease: clinical presentation, diagnosis and prognosis in women","volume":"20","author":"Leuzzi","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"B96","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.jacc.2009.04.098","article-title":"Women and ischemic heart disease: evolving knowledge","volume":"54","author":"Shaw","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/clc.21966","article-title":"Myocardial ischemia in women: lessons from the NHLBI WISE study","volume":"35","author":"Gulati","year":"2012","journal-title":"Clin Cardiol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/clc.22917","article-title":"Sex differences in heart failure","volume":"41","author":"Eisenberg","year":"2018","journal-title":"Clin Cardiol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1161\/CIRCULATIONAHA.112.105718","article-title":"Clinical features, management, and prognosis of spontaneous coronary artery dissection","volume":"126","author":"Tweet","year":"2012","journal-title":"Circulation"},{"key":"B100","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1161\/01.HYP.25.2.155","article-title":"Hypertension and the pathogenesis of atherosclerosis","volume":"25","author":"Alexander","year":"1995","journal-title":"Hypertension"},{"key":"B101","doi-asserted-by":"publisher","first-page":"959285","DOI":"10.3389\/fcvm.2022.959285","article-title":"Hypertension as a risk factor for atherosclerosis: cardiovascular risk assessment","volume":"9","author":"Poznyak","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B102","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/2314808X.2020.1769913","article-title":"Basic pathogenic mechanisms of atherosclerosis","volume":"7","author":"Alfarisi","year":"2020","journal-title":"Egypt J Basic Appl Sci"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1161\/CIRCRESAHA.114.301137","article-title":"Artery tertiary lymphoid organs contribute to innate and adaptive immune responses in advanced mouse atherosclerosis","volume":"114","author":"Mohanta","year":"2014","journal-title":"Circ Res"},{"key":"B104","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.immuni.2012.06.021","article-title":"T cell affinity regulates asymmetric division, effector cell differentiation, and tissue pathology","volume":"37","author":"King","year":"2012","journal-title":"Immunity"},{"key":"B105","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41586-022-04673-6","article-title":"Neuroimmune cardiovascular interfaces control atherosclerosis","volume":"605","author":"Mohanta","year":"2022","journal-title":"Nature"},{"key":"B106","doi-asserted-by":"publisher","first-page":"27","DOI":"10.5551\/jat.RV17014","article-title":"Mechanism of development of atherosclerosis and cardiovascular disease in diabetes Mellitus","volume":"25","author":"Katakami","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"B107","doi-asserted-by":"publisher","first-page":"3013","DOI":"10.1093\/eurheartj\/ehu353","article-title":"Biomechanical factors in atherosclerosis: mechanisms and clinical implications\u2020","volume":"35","author":"Kwak","year":"2014","journal-title":"Eur Heart J"},{"key":"B108","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nature10146","article-title":"Progress and challenges in translating the biology of atherosclerosis","volume":"473","author":"Libby","year":"2011","journal-title":"Nature"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.3390\/nu11091970","article-title":"Sodium intake and hypertension","volume":"11","author":"Grillo","year":"2019","journal-title":"Nutrients"},{"key":"B110","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.jhh.1001459","article-title":"Effect of modest salt reduction on blood pressure: a meta-analysis of randomized trials. Implications for public health","volume":"16","author":"He","year":"2002","journal-title":"J Hum Hypertens"},{"key":"B111","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11906-019-0956-5","article-title":"Patho-immune mechanisms of hypertension in HIV: a systematic and thematic review","volume":"21","author":"Masenga","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1186\/s40885-020-00160-0","article-title":"HIV-positive demonstrate more salt sensitivity and nocturnal non-dipping blood pressure than HIV-negative individuals","volume":"27","author":"Masenga","year":"2021","journal-title":"Clin Hypertens"},{"key":"B113","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s40885-022-00209-2","article-title":"Immediate pressor response to oral salt and its assessment in the clinic: a time series clinical trial","volume":"28","author":"Masenga","year":"2022","journal-title":"Clin Hypertens"},{"key":"B114","first-page":"85","article-title":"Salt-sensitivity in normotensive and hypertensive Nigerians","volume":"21","author":"Elias","year":"2011","journal-title":"Nig Q J Hosp Med"},{"key":"B115","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/jch.13535","article-title":"Salt-induced effects on microvascular function: a critical factor in hypertension mediated organ damage","volume":"21","author":"Marketou","year":"2019","journal-title":"J Clin Hypertens"},{"key":"B116","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1136\/bmj.302.6780.819","article-title":"By how much does dietary salt reduction lower blood pressure? III\u2013analysis of data from trials of salt reduction","volume":"302","author":"Law","year":"1991","journal-title":"Br Med J"},{"key":"B117","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1136\/bmj.293.6538.27","article-title":"Does sodium restriction lower blood pressure?","volume":"293","author":"Grobbee","year":"1986","journal-title":"Br Med J (Clin Res Ed)"},{"key":"B118","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1136\/bmj.325.7365.628","article-title":"Systematic review of long term effects of advice to reduce dietary salt in adults","volume":"325","author":"Hooper","year":"2002","journal-title":"Br Med J"},{"key":"B119","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1038\/sj.jhh.1001575","article-title":"Blood pressure response to changes in sodium and potassium intake: a metaregression analysis of randomised trials","volume":"17","author":"Geleijnse","year":"2003","journal-title":"J Hum Hypertens"},{"key":"B120","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1001\/jama.1996.03530440070039","article-title":"Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials","volume":"275","author":"Midgley","year":"1996","journal-title":"JAMA"},{"key":"B121","doi-asserted-by":"publisher","first-page":"643S","DOI":"10.1093\/ajcn\/65.2.643S","article-title":"Randomized trials of sodium reduction: an overview","volume":"65","author":"Cutler","year":"1997","journal-title":"Am J Clin Nutr"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004022.pub5","article-title":"Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride","author":"Graudal","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"B123","doi-asserted-by":"publisher","first-page":"f1326","DOI":"10.1136\/bmj.f1326","article-title":"Effect of lower sodium intake on health: systematic review and meta-analyses","volume":"346","author":"Aburto","year":"2013","journal-title":"Br Med J"},{"key":"B124","doi-asserted-by":"publisher","first-page":"f1325","DOI":"10.1136\/bmj.f1325","article-title":"Effect of longer term modest salt reduction on blood pressure: cochrane systematic review and meta-analysis of randomised trials","volume":"346","author":"He","year":"2013","journal-title":"Br Med J"},{"key":"B125","doi-asserted-by":"publisher","first-page":"e660","DOI":"10.1161\/CIR.0000000000000051","article-title":"Stakeholder discussion to reduce population-wide sodium intake and decrease sodium in the food supply","volume":"129","author":"Antman","year":"2014","journal-title":"Circulation"},{"key":"B126","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1186\/1475-2891-12-163","article-title":"Challenges in sodium intake reduction and meal consumption patterns among participants with metabolic syndrome in a dietary trial","volume":"12","author":"Wang","year":"2013","journal-title":"Nutr J"},{"key":"B127","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1161\/HYP.0000000000000047","article-title":"Salt sensitivity of blood pressure","volume":"68","author":"Elijovich","year":"2016","journal-title":"Hypertension"},{"key":"B128","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s11906-022-01201-9","article-title":"Inverse salt sensitivity of blood pressure: mechanisms and potential relevance for prevention of cardiovascular disease","volume":"24","author":"Felder","year":"2022","journal-title":"Curr Hypertens Rep"},{"key":"B129","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1161\/HYPERTENSIONAHA.112.196071","article-title":"Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter","volume":"60","author":"Carey","year":"2012","journal-title":"Hypertension"},{"key":"B130","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.675230","article-title":"Candidate gene polymorphisms influence the susceptibility to salt sensitivity of blood pressure in a han Chinese population: risk factors as mediators","volume":"12","author":"Xie","year":"2021","journal-title":"Front Genet"},{"key":"B131","doi-asserted-by":"publisher","first-page":"ckab165","DOI":"10.1093\/eurpub\/ckab165.290","article-title":"Study of rs10177833 polymorphism in SLC4A5 gene and salt sensitivity in Bulgarian population","volume":"31","author":"Georgieva","year":"2021","journal-title":"Eur J Public Health"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e432","DOI":"10.1371\/journal.pone.0000432","article-title":"Polymorphism in NEDD4l is associated with increased salt sensitivity, reduced levels of P-renin and increased levels of nt-proANP","volume":"2","author":"Dahlberg","year":"2007","journal-title":"PLoS One"},{"key":"B133","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1007\/s13668-013-0047-1","article-title":"Dietary salt intake, blood pressure, and genes","volume":"2","author":"Lupoli","year":"2013","journal-title":"Curr Nutr Rep"},{"key":"B134","doi-asserted-by":"publisher","first-page":"1001434","DOI":"10.3389\/fphys.2022.1001434","article-title":"Pathophysiology and genetics of salt-sensitive hypertension","volume":"13","author":"Maaliki","year":"2022","journal-title":"Front Physiol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3945\/ajcn.2009.29028","article-title":"Salt sensitivity is associated with insulin resistance, sympathetic overactivity, and decreased suppression of circulating renin activity in lean patients with essential hypertension","volume":"92","author":"Yatabe","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"B136","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1161\/01.HYP.0000056768.03657.B4","article-title":"Enhancement of intrarenal angiotensinogen in dahl salt-sensitive rats on high salt diet","volume":"41","author":"Kobori","year":"2003","journal-title":"Hypertension"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1681\/ASN.2013121258","article-title":"Mechanism of salt-sensitive hypertension: focus on adrenal and sympathetic nervous systems","volume":"25","author":"Fujita","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1097\/HJH.0b013e3283440683","article-title":"Salt-induced renal injury in SHRs is mediated by AT1 receptor activation","volume":"29","author":"Susic","year":"2011","journal-title":"J Hypertens"},{"key":"B139","doi-asserted-by":"publisher","first-page":"R706","DOI":"10.1152\/ajpregu.00250.2017","article-title":"A new paradigm of sodium regulation in inflammation and hypertension","volume":"313","author":"Kirabo","year":"2017","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1038\/nm.1960","article-title":"Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C\u2013dependent buffering mechanism","volume":"15","author":"Machnik","year":"2009","journal-title":"Nat Med"},{"key":"B141","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.it.2021.04.002","article-title":"Sodium and its manifold impact on our immune system","volume":"42","author":"Jobin","year":"2021","journal-title":"Trends Immunol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/brain\/awp334","article-title":"Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla","volume":"133","author":"Inglese","year":"2010","journal-title":"Brain"},{"key":"B143","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1093\/rheumatology\/kew371","article-title":"Na+ deposition in the fibrotic skin of systemic sclerosis patients detected by 23Na-magnetic resonance imaging","volume":"56","author":"Kopp","year":"2017","journal-title":"Rheumatology"},{"key":"B144","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/oby.22090","article-title":"Tissue sodium content is elevated in the skin and subcutaneous adipose tissue in women with lipedema","volume":"26","author":"Crescenzi","year":"2018","journal-title":"Obesity"},{"key":"B145","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.jid.2021.06.013","article-title":"Skin sodium accumulates in psoriasis and reflects disease severity","volume":"142","author":"Maifeld","year":"2022","journal-title":"J Invest Dermatol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1177\/0961203320908934","article-title":"Tissue sodium content in patients with systemic lupus erythematosus: association with disease activity and markers of inflammation","volume":"29","author":"Carranza-Le\u03ccn","year":"2020","journal-title":"Lupus"},{"key":"B147","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.109.143339","article-title":"Mononuclear phagocyte system depletion blocks interstitial tonicity-responsive enhancer binding protein\/vascular endothelial growth factor C expression and induces salt-sensitive hypertension in rats","volume":"55","author":"Machnik","year":"2010","journal-title":"Hypertension"},{"key":"B148","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1161\/HYPERTENSIONAHA.116.08565","article-title":"Salt sensitivity of angiogenesis inhibition\u2013induced blood pressure rise","volume":"69","author":"Lankhorst","year":"2017","journal-title":"Hypertension"},{"key":"B149","doi-asserted-by":"publisher","first-page":"2803","DOI":"10.1172\/JCI60113","article-title":"Immune cells control skin lymphatic electrolyte homeostasis and blood pressure","volume":"123","author":"Wiig","year":"2013","journal-title":"J Clin Invest"},{"key":"B150","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s11906-018-0892-9","article-title":"Skin sodium and hypertension: a paradigm shift?","volume":"20","author":"Selvarajah","year":"2018","journal-title":"Curr Hypertens Rep"},{"key":"B151","doi-asserted-by":"publisher","first-page":"G36","DOI":"10.1152\/ajpgi.00552.2004","article-title":"Subcloning, localization, and expression of the rat intestinal sodium-hydrogen exchanger isoform 8","volume":"289","author":"Xu","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/labinvest.2008.114","article-title":"Recent advances in the renal\u2013skeletal\u2013gut axis that controls phosphate homeostasis","volume":"89","author":"Kiela","year":"2009","journal-title":"Lab Invest"},{"key":"B153","doi-asserted-by":"publisher","first-page":"C1937","DOI":"10.1152\/ajpcell.1997.273.6.C1937","article-title":"Functional and molecular characterization of NHE3 expression during ontogeny in rat jejunal epithelium","volume":"273","author":"Collins","year":"1997","journal-title":"Am J Physiol Cell Physiol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"3938","DOI":"10.1073\/pnas.90.9.3938","article-title":"Molecular cloning, sequencing, tissue distribution, and functional expression of a na+\/H+ exchanger (NHE-2)","volume":"90","author":"Collins","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s00424-014-1577-0","article-title":"Sodium selective erythrocyte glycocalyx and salt sensitivity in man","volume":"467","author":"Oberleithner","year":"2015","journal-title":"Pflugers Arch"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e0264650","DOI":"10.1371\/journal.pone.0264650","article-title":"Erythrocyte sodium buffering capacity status correlates with self-reported salt intake in a population from livingstone, Zambia","volume":"17","author":"Masenga","year":"2022","journal-title":"PLoS One"},{"key":"B157","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1161\/HYPERTENSIONAHA.110.155747","article-title":"Effect of modest salt reduction on skin capillary rarefaction in white, black, and Asian individuals with mild hypertension","volume":"56","author":"He","year":"2010","journal-title":"Hypertension"},{"key":"B158","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1161\/HYPERTENSIONAHA.116.07289","article-title":"Hemodynamics and salt-and-water balance link sodium storage and vascular dysfunction in salt-sensitive subjects","volume":"68","author":"Laffer","year":"2016","journal-title":"Hypertension"},{"key":"B159","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00424-011-0999-1","article-title":"Salt overload damages the glycocalyx sodium barrier of vascular endothelium","volume":"462","author":"Oberleithner","year":"2011","journal-title":"Pflugers Arch"},{"key":"B160","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.prostaglandins.2018.09.008","article-title":"Mechanisms of isolevuglandin-protein adduct formation in inflammation and hypertension","volume":"139","author":"Xiao","year":"2018","journal-title":"Prostaglandins Other Lipid Mediators"},{"key":"B161","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/cvr\/cvaa207","article-title":"Sodium activates human monocytes via the NADPH oxidase and isolevuglandin formation","author":"Barbaro","year":"2020","journal-title":"Cardiovasc Res"},{"key":"B162","doi-asserted-by":"publisher","first-page":"4642","DOI":"10.1172\/JCI74084","article-title":"DC isoketal-modified proteins activate T cells and promote hypertension","volume":"124","author":"Kirabo","year":"2014","journal-title":"J Clin Invest"},{"key":"B163","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41581-019-0121-z","article-title":"Immune mechanisms of salt-sensitive hypertension and renal end-organ damage","volume":"15","author":"Mattson","year":"2019","journal-title":"Nat Rev Nephrol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"F499","DOI":"10.1152\/ajprenal.00258.2014","article-title":"Infiltrating immune cells in the kidney in salt-sensitive hypertension and renal injury","volume":"307","author":"Mattson","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"B165","doi-asserted-by":"publisher","first-page":"F734","DOI":"10.1152\/ajprenal.00454.2010","article-title":"Infiltrating T lymphocytes in the kidney increase oxidative stress and participate in the development of hypertension and renal disease","volume":"300","author":"Miguel","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"B166","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/ijms22031064","article-title":"Emerging role of the inflammasome and pyroptosis in hypertension","volume":"22","author":"De Miguel","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B167","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1161\/CIRCRESAHA.122.320818","article-title":"DC ENaC-Dependent inflammasome activation contributes to salt-sensitive hypertension","volume":"131","author":"Pitzer","year":"2022","journal-title":"Circ Res"},{"key":"B168","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.3390\/ijms22062958","article-title":"Role of rho in salt-sensitive hypertension","volume":"22","author":"Kawarazaki","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B169","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1159\/000515088","article-title":"Pathogenesis of higher blood pressure and worse renal function in salt-sensitive hypertension","volume":"46","author":"Chu","year":"2021","journal-title":"KBR"},{"key":"B170","doi-asserted-by":"publisher","first-page":"783","DOI":"10.3892\/mmr.2018.9713","article-title":"PI3K\/Akt Signaling transduction pathway, erythropoiesis and glycolysis in hypoxia","volume":"19","author":"Xie","year":"2019","journal-title":"Mol Med Rep"},{"key":"B171","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1111\/j.1476-5381.2012.01832.x","article-title":"Renin activates PI3K-akt-eNOS signalling through the angiotensin AT1 and Mas receptors to modulate central blood pressure control in the nucleus tractus solitarii","volume":"166","author":"Cheng","year":"2012","journal-title":"Br J Pharmacol"},{"key":"B172","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3390\/cells11091553","article-title":"Insight into the role of the PI3K\/akt pathway in ischemic injury and post-infarct left ventricular remodeling in normal and diabetic heart","volume":"11","author":"Walkowski","year":"2022","journal-title":"Cells"},{"key":"B173","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/01.RES.0000031956.29928.62","article-title":"Phosphatidylinositol 3-kinase","volume":"91","author":"Sata","year":"2002","journal-title":"Circ Res"},{"key":"B174","doi-asserted-by":"publisher","first-page":"9767","DOI":"10.1007\/s11033-022-07468-0","article-title":"Interplay between PI3K\/AKT pathway and heart disorders","volume":"49","author":"Ghafouri-Fard","year":"2022","journal-title":"Mol Biol Rep"},{"key":"B175","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12931-020-01598-4","article-title":"Resistin-like molecule \u03b2 acts as a mitogenic factor in hypoxic pulmonary hypertension via the Ca2+-dependent PI3K\/akt\/mTOR and PKC\/MAPK signaling pathways","volume":"22","author":"Tian","year":"2021","journal-title":"Respir Res"},{"key":"B176","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/s41440-020-0437-x","article-title":"The WNK signaling pathway and salt-sensitive hypertension","volume":"43","author":"Furusho","year":"2020","journal-title":"Hypertens Res"},{"key":"B177","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1093\/ndt\/gfv259","article-title":"Kelch-like 3\/cullin 3 ubiquitin ligase complex and WNK signaling in salt-sensitive hypertension and electrolyte disorder","volume":"31","author":"Sohara","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00233","article-title":"Brain G\u03b1i2-subunit proteins and the prevention of salt sensitive hypertension","volume":"6","author":"Carmichael","year":"2015","journal-title":"Front Physiol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1161\/HYPERTENSIONAHA.114.04463","article-title":"G\u03b1i2-protein\u2013mediated signal transduction","volume":"65","author":"Wainford","year":"2015","journal-title":"Hypertension"},{"key":"B180","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1161\/01.HYP.0000237975.90870.eb","article-title":"Angiotensin II signal transduction through small GTP-binding proteins","volume":"48","author":"Ohtsu","year":"2006","journal-title":"Hypertension"},{"key":"B181","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.cardiores.2006.05.001","article-title":"Redox signaling in hypertension","volume":"71","author":"Paravicini","year":"2006","journal-title":"Cardiovasc Res"},{"key":"B182","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/ajh.2008.178","article-title":"Change of genetic determinants of left ventricular structure in adolescence: longitudinal evidence from the Georgia cardiovascular twin study","volume":"21","author":"Kapuku","year":"2008","journal-title":"Am J Hypertens"},{"key":"B183","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/S0895-7061(01)02200-2","article-title":"Sibling correlation of left ventricular mass and geometry in hypertensive African Americans and whites: the HyperGEN study*","volume":"14","author":"Arnett","year":"2001","journal-title":"Am J Hypertens"},{"key":"B184","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1161\/01.HYP.30.5.1025","article-title":"Heritability of left ventricular mass","volume":"30","author":"Post","year":"1997","journal-title":"Hypertension"},{"key":"B185","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1001\/jama.2009.978-a","article-title":"Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data","volume":"302","author":"Vasan","year":"2009","journal-title":"JAMA"},{"key":"B186","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/ng.134","article-title":"Integrated genomic approaches implicate osteoglycin (ogn) in the regulation of left ventricular mass","volume":"40","author":"Petretto","year":"2008","journal-title":"Nat Genet"},{"key":"B187","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/nature06007","article-title":"Variants conferring risk of atrial fibrillation on chromosome 4q25","volume":"448","author":"Gudbjartsson","year":"2007","journal-title":"Nature"},{"key":"B188","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1136\/heartjnl-2016-311027","article-title":"Genomic basis of atrial fibrillation","volume":"104","author":"Bapat","year":"2018","journal-title":"Heart"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1161\/CIRCULATIONAHA.114.009892","article-title":"Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation","volume":"130","author":"Sinner","year":"2014","journal-title":"Circulation"},{"key":"B190","doi-asserted-by":"publisher","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.111.019893","article-title":"Atrial fibrillation pathophysiology","volume":"124","author":"Iwasaki","year":"2011","journal-title":"Circulation"},{"key":"B191","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/HCO.0000000000000505","article-title":"Genetics of atrial fibrillation: an update","volume":"33","author":"Campbell","year":"2018","journal-title":"Curr Opin Cardiol"},{"key":"B192","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.111.00275","article-title":"Genetic predisposition to higher blood pressure increases coronary artery disease risk","volume":"61","author":"Lieb","year":"2013","journal-title":"Hypertension"},{"key":"B193","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1161\/HYPERTENSIONAHA.115.05961","article-title":"Genetic predisposition to higher blood pressure increases risk of incident hypertension and cardiovascular diseases in Chinese","volume":"66","author":"Lu","year":"2015","journal-title":"Hypertension"},{"key":"B194","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s43044-022-00240-6","article-title":"Genetic predisposition study of heart failure and its association with cardiomyopathy","volume":"74","author":"Kaviarasan","year":"2022","journal-title":"Egypt Heart J"},{"key":"B195","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1161\/CIRCULATIONAHA.117.030898","article-title":"Genetic predisposition to high blood pressure and lifestyle factors","volume":"137","author":"Pazoki","year":"2018","journal-title":"Circulation"},{"key":"B196","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2017.00285","article-title":"Genetic programming of hypertension","volume":"5","author":"Ahn","year":"2018","journal-title":"Front Pediatr"},{"key":"B197","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.jacbts.2020.09.004","article-title":"Genetic risk stratification","volume":"6","author":"Roberts","year":"2021","journal-title":"JACC Basic Transl Sci"},{"key":"B198","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11906-010-0174-7","article-title":"Genetics of hypertension and cardiovascular disease and their interconnected pathways: lessons from large studies","volume":"13","author":"Kraja","year":"2011","journal-title":"Curr Hypertens Rep"},{"key":"B199","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1093\/eurheartj\/ehx273","article-title":"Understanding the role of genetics in hypertension","volume":"38","author":"Patel","year":"2017","journal-title":"Eur Heart J"},{"key":"B200","doi-asserted-by":"publisher","first-page":"e0208645","DOI":"10.1371\/journal.pone.0208645","article-title":"Hypertension genetic risk score is associated with burden of coronary heart disease among patients referred for coronary angiography","volume":"13","author":"Krogager","year":"2018","journal-title":"PLoS One"},{"key":"B201","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.jacc.2006.03.072","article-title":"Traditional cardiovascular risk factors in relation to left ventricular mass, volume, and systolic function by cardiac magnetic resonance imaging: the multiethnic study of atherosclerosis","volume":"48","author":"Heckbert","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"290","DOI":"10.3978\/j.issn.2223-3652.2015.06.07","article-title":"Cardiac MR imaging: current status and future direction","volume":"5","author":"Saeed","year":"2015","journal-title":"Cardiovasc Diagn Ther"},{"key":"B203","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology and the European society of hypertension","volume":"36","author":"Williams","year":"2018","journal-title":"J Hypertens"},{"key":"B204","doi-asserted-by":"publisher","first-page":"3308","DOI":"10.1093\/eurheartj\/ehx525","article-title":"The effect of sacubitril\/valsartan compared to olmesartan on cardiovascular remodelling in subjects with essential hypertension: the results of a randomized, double-blind, active-controlled study","volume":"38","author":"Schmieder","year":"2017","journal-title":"Eur Heart J"},{"key":"B205","doi-asserted-by":"publisher","first-page":"558","DOI":"10.3109\/10641963.2011.577486","article-title":"The effects of simvastatin on left ventricular hypertrophy and left ventricular function in patients with essential hypertension","volume":"33","author":"Pan","year":"2011","journal-title":"Clin Exp Hypertens"},{"key":"B206","doi-asserted-by":"publisher","first-page":"109539","DOI":"10.1016\/j.biopha.2019.109539","article-title":"Long-term effect of the perindopril\/indapamide\/amlodipine single-pill combination on left ventricular hypertrophy in outpatient hypertensive subjects","volume":"120","author":"Mazza","year":"2019","journal-title":"Biomed Pharmacother"},{"key":"B207","first-page":"1446","article-title":"Efficacy of high dose allopurinol in reducing left ventricular mass in patients with left ventricular hypertrophy by comparing its efficacy with febuxostat\u2014a randomized controlled trial","volume":"68","author":"Lal","year":"2018","journal-title":"J Pak Med Assoc"},{"key":"B208","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1097\/HJH.0000000000002189","article-title":"Allopurinol treatment adversely impacts left ventricular mass regression in patients with well-controlled hypertension","volume":"37","author":"Gingles","year":"2019","journal-title":"J Hypertens"},{"key":"B209","doi-asserted-by":"publisher","first-page":"2039","DOI":"10.1097\/HJH.0b013e328356b850","article-title":"Hypertensive left ventricular hypertrophy: a mechanistic approach to optimizing regression assessed by cardiovascular magnetic resonance","volume":"30","author":"Burns","year":"2012","journal-title":"J Hypertens"},{"key":"B210","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.clnu.2019.06.026","article-title":"A nutraceutical combination reduces left ventricular mass in subjects with metabolic syndrome and left ventricular hypertrophy: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"39","author":"Mercurio","year":"2020","journal-title":"Clin Nutr"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1111\/echo.12548","article-title":"Impact of azelnidipine and amlodipine on left ventricular mass and longitudinal function in hypertensive patients with left ventricular hypertrophy","volume":"31","author":"Motoki","year":"2014","journal-title":"Echocardiography"},{"key":"B212","first-page":"1323","article-title":"Effects of losartan on left ventricular mass: a three-year follow-up in elderly hypertensives with myocardial hypertrophy despite successful conventional antihypertensive treatment","volume":"21","author":"Moroni","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"B213","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1097\/HJH.0000000000001264","article-title":"Low-dose eplerenone decreases left ventricular mass in treatment-resistant hypertension","volume":"35","author":"Schneider","year":"2017","journal-title":"J Hypertens"},{"key":"B214","doi-asserted-by":"publisher","first-page":"3409","DOI":"10.1093\/eurheartj\/ehz203","article-title":"A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial","volume":"40","author":"Mohan","year":"2019","journal-title":"Eur Heart J"},{"key":"B215","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1161\/HYPERTENSIONAHA.111.178616","article-title":"Left ventricular mass and function with reduced-fat or reduced-carbohydrate hypocaloric diets in overweight and obese subjects","volume":"59","author":"Haufe","year":"2012","journal-title":"Hypertension"},{"key":"B216","doi-asserted-by":"publisher","first-page":"e14030","DOI":"10.14814\/phy2.14030","article-title":"Regular consumption of green tea improves pulse pressure and induces regression of left ventricular hypertrophy in hypertensive patients","volume":"7","author":"Al-Shafei","year":"2019","journal-title":"Physiol Rep"},{"key":"B217","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"B218","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni","year":"2021","journal-title":"N Engl J Med"},{"key":"B219","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/europace\/euab029","article-title":"Cryoballoon ablation vs. Antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation","volume":"23","author":"Kuniss","year":"2021","journal-title":"Europace"},{"key":"B220","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/eurheartj\/ehab593","article-title":"Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial","volume":"43","author":"Willems","year":"2022","journal-title":"Eur Heart J"},{"key":"B221","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1093\/europace\/euaa298","article-title":"Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST)","volume":"23","author":"Kuck","year":"2021","journal-title":"Europace"},{"key":"B222","doi-asserted-by":"publisher","first-page":"e007073","DOI":"10.1161\/CIRCEP.118.007073","article-title":"Atrial fibrillation catheter ablation increases the left atrial pressure","volume":"12","author":"Park","year":"2019","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B223","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jacep.2022.03.012","article-title":"Circumferential pulmonary vein isolation plus low-voltage area modification in persistent atrial fibrillation: the STABLE-SR-II trial","volume":"8","author":"Yang","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"B224","doi-asserted-by":"publisher","first-page":"e2239380","DOI":"10.1001\/jamanetworkopen.2022.39380","article-title":"Effect of high-intensity interval training in patients with atrial fibrillation: a randomized clinical trial","volume":"5","author":"Reed","year":"2022","journal-title":"JAMA Netw Open"},{"key":"B225","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1093\/eurheartj\/ehy148","article-title":"Apixaban compared to heparin\/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial","volume":"39","author":"Ezekowitz","year":"2018","journal-title":"Eur Heart J"},{"key":"B226","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/eurheartj\/ehz059","article-title":"Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial","volume":"40","author":"Oldgren","year":"2019","journal-title":"Eur Heart J"},{"key":"B227","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.1093\/eurheartj\/ehx739","article-title":"Targeted therapy of underlying conditions improves sinus rhythm maintenance in patients with persistent atrial fibrillation: results of the RACE 3 trial","volume":"39","author":"Rienstra","year":"2018","journal-title":"Eur Heart J"},{"key":"B228","doi-asserted-by":"publisher","first-page":"e011367","DOI":"10.1161\/JAHA.118.011367","article-title":"Anti-Inflammatory effects of a vegan diet versus the American heart association-recommended diet in coronary artery disease trial","volume":"7","author":"Shah","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"B229","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1161\/STROKEAHA.120.033214","article-title":"Mediterranean Diet reduces atherosclerosis progression in coronary heart disease: an analysis of the CORDIOPREV randomized controlled trial","volume":"52","author":"Jimenez-Torres","year":"2021","journal-title":"Stroke"},{"key":"B230","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamacardio.2022.1561","article-title":"Rivaroxaban monotherapy vs combination therapy with antiplatelets on total thrombotic and bleeding events in atrial fibrillation with stable coronary artery disease: a post hoc secondary analysis of the AFIRE trial","volume":"7","author":"Naito","year":"2022","journal-title":"JAMA Cardiol"},{"key":"B231","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1161\/CIRCULATIONAHA.119.039609","article-title":"Rivaroxaban with or without aspirin in patients with heart failure and chronic coronary or peripheral artery disease","volume":"140","author":"Branch","year":"2019","journal-title":"Circulation"},{"key":"B232","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1161\/CIRCULATIONAHA.121.058233","article-title":"Long-term efficacy of colchicine in patients with chronic coronary disease: insights from LoDoCo2","volume":"145","author":"Opstal","year":"2022","journal-title":"Circulation"},{"key":"B233","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12933-019-0934-x","article-title":"Effects of 1 year of exercise training versus combined exercise training and weight loss on body composition, low-grade inflammation and lipids in overweight patients with coronary artery disease: a randomized trial","volume":"18","author":"Pedersen","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B234","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.pcad.2021.07.002","article-title":"The effects of high-intensity interval training, nordic walking and moderate-to-vigorous intensity continuous training on functional capacity, depression and quality of life in patients with coronary artery disease enrolled in cardiac rehabilitation: a randomized controlled trial (CRX study)","volume":"70","author":"Reed","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"key":"B235","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1136\/heartjnl-2019-316056","article-title":"Lifestyle modification in older versus younger patients with coronary artery disease","volume":"106","author":"Jepma","year":"2020","journal-title":"Heart"},{"key":"B236","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1161\/CIRCULATIONAHA.118.034309","article-title":"Clinical benefit of evolocumab by severity and extent of coronary artery disease: analysis from FOURIER","volume":"138","author":"Sabatine","year":"2018","journal-title":"Circulation"},{"key":"B237","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.121.054117","article-title":"One-year committed exercise training reverses abnormal left ventricular myocardial stiffness in patients with stage B heart failure with preserved ejection fraction","volume":"144","author":"Hieda","year":"2021","journal-title":"Circulation"},{"key":"B238","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1161\/CIRCULATIONAHA.122.059785","article-title":"Empagliflozin for heart failure with preserved left ventricular ejection fraction with and without diabetes","volume":"146","author":"Filippatos","year":"2022","journal-title":"Circulation"},{"key":"B239","doi-asserted-by":"publisher","first-page":"e010080","DOI":"10.1161\/CIRCHEARTFAILURE.122.010080","article-title":"Efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction according to age: the DELIVER trial","volume":"15","author":"Peikert","year":"2022","journal-title":"Circ Heart Fail"},{"key":"B240","doi-asserted-by":"publisher","first-page":"e011521","DOI":"10.1161\/JAHA.118.011521","article-title":"Myocardial effects of aldosterone antagonism in heart failure with preserved ejection fraction","volume":"9","author":"McDiarmid","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B241","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1016\/j.jacc.2021.03.232","article-title":"Individualized nutritional support for hospitalized patients with chronic heart failure","volume":"77","author":"Hersberger","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"B242","doi-asserted-by":"publisher","first-page":"e009337","DOI":"10.1161\/CIRCHEARTFAILURE.121.009337","article-title":"Vericiguat and health-related quality of life in patients with heart failure with reduced ejection fraction: insights from the VICTORIA trial","volume":"15","author":"Butler","year":"2022","journal-title":"Circ Heart Fail"},{"key":"B243","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.arcmed.2016.11.005","article-title":"Nutritional intervention in malnourished hospitalized patients with heart failure","volume":"47","author":"Bonilla-Palomas","year":"2016","journal-title":"Arch Med Res"},{"key":"B244","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12872-022-02572-2","article-title":"Use of levosimendan combined with shenfu injection to treat acute heart failure patients with hypotension: a prospective randomized controlled single-blind study","volume":"22","author":"Li","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"B245","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1001\/jamacardio.2021.4027","article-title":"Assessment of omecamtiv mecarbil for the treatment of patients with severe heart failure: a post hoc analysis of data from the GALACTIC-HF randomized clinical trial","volume":"7","author":"Felker","year":"2022","journal-title":"JAMA Cardiol"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1205475\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T05:21:55Z","timestamp":1685942515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1205475\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,5]]},"references-count":245,"alternative-id":["10.3389\/fcvm.2023.1205475"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1205475","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,5]]},"article-number":"1205475"}}